Clinical manifestations and comorbidities in axial and peripheral spondyloarthritis. Front Med (Lausanne). 2022 Aug 12;9:980732. (2022)
https://pubmed.ncbi.nlm.nih.gov/36035397/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry (2021)
https://pubmed.ncbi.nlm.nih.gov/32856083/

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. (2018)
https://pubmed.ncbi.nlm.nih.gov/29038299/

Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project (2018)
https://pubmed.ncbi.nlm.nih.gov/28754402/

Assessment of Fatigue in Spondyloarthritis and Its Association with Disease Activity (2016)
https://pubmed.ncbi.nlm.nih.gov/26879350/

Candidate’s single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis (2014)
https://pubmed.ncbi.nlm.nih.gov/24337767/

Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis (2012)
https://pubmed.ncbi.nlm.nih.gov/22984424/

Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis (2011)
https://pubmed.ncbi.nlm.nih.gov/20823095/

Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis (2011)
https://pubmed.ncbi.nlm.nih.gov/21221691/